| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | HSPG2 FRAS1 THBS2 FBN2 VWF TNC LAMA2 LAMA3 LAMA5 ZP4 SSPOP MUC6 | 1.08e-12 | 188 | 66 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | JAG2 TPO HSPG2 THBS2 FBN2 PROZ MEGF8 NCAN DNER CDH3 NOTCH2 NOTCH3 CRB2 MASP2 | 1.23e-07 | 749 | 66 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | HSPG2 FRAS1 THBS2 FBN2 VWF TNC KRTAP1-3 LAMA2 LAMA3 LAMA5 KRTAP26-1 ZP4 SSPOP MUC6 OTOG | 1.57e-07 | 891 | 66 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | neuregulin receptor activity | 3.22e-05 | 3 | 66 | 2 | GO:0038131 | |
| GeneOntologyMolecularFunction | Notch binding | 9.53e-05 | 27 | 66 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 9.53e-05 | 27 | 66 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | neuregulin binding | 1.60e-04 | 6 | 66 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | class I DNA-(apurinic or apyrimidinic site) endonuclease activity | 2.97e-04 | 8 | 66 | 2 | GO:0140078 | |
| GeneOntologyMolecularFunction | DNA N-glycosylase activity | 9.54e-04 | 14 | 66 | 2 | GO:0019104 | |
| GeneOntologyMolecularFunction | DNA-(apurinic or apyrimidinic site) endonuclease activity | 9.54e-04 | 14 | 66 | 2 | GO:0003906 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.30e-03 | 65 | 66 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.32e-03 | 144 | 66 | 4 | GO:0016798 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.81e-03 | 85 | 66 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.81e-03 | 85 | 66 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | opsonin binding | 3.07e-03 | 25 | 66 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | complement binding | 5.01e-03 | 32 | 66 | 2 | GO:0001848 | |
| GeneOntologyBiologicalProcess | axon development | SCARF1 HSPG2 MEGF8 DRAXIN TNC LAMA2 LAMA3 LAMA5 GRN GOLGA8A NOTCH2 NOTCH3 | 7.90e-07 | 642 | 66 | 12 | GO:0061564 |
| GeneOntologyBiologicalProcess | axon guidance | 3.46e-06 | 285 | 66 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 3.55e-06 | 286 | 66 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | embryo development | JAG2 TPO PCSK5 HSPG2 FRAS1 ERBB4 FBN2 MEGF8 TIE1 LAMA2 LAMA3 LAMA5 GRN NOTCH2 CRB2 | 3.75e-05 | 1437 | 66 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 3.97e-05 | 197 | 66 | 6 | GO:0030509 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 6.27e-05 | 131 | 66 | 5 | GO:0030510 | |
| GeneOntologyBiologicalProcess | response to BMP | 6.45e-05 | 215 | 66 | 6 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 6.45e-05 | 215 | 66 | 6 | GO:0071773 | |
| GeneOntologyBiologicalProcess | axonogenesis | 7.61e-05 | 566 | 66 | 9 | GO:0007409 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 8.47e-05 | 445 | 66 | 8 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.19e-04 | 347 | 66 | 7 | GO:0090092 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.47e-04 | 482 | 66 | 8 | GO:0007178 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 1.50e-04 | 6 | 66 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 1.50e-04 | 6 | 66 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | JAG2 PCSK5 VWC2 HSPG2 ERBB3 TNC LAMA2 LAMA3 LAMA5 ZP4 MEGF10 | 1.59e-04 | 927 | 66 | 11 | GO:0030155 |
| GeneOntologyBiologicalProcess | neuron development | SCARF1 HSPG2 MEGF8 DRAXIN TNC LAMA2 LAMA3 LAMA5 GRN GOLGA8A NOTCH2 NOTCH3 CRB2 OTOG | 1.80e-04 | 1463 | 66 | 14 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | SCARF1 HSPG2 MEGF8 DRAXIN TNC LAMA2 LAMA3 LAMA5 GRN GOLGA8A NOTCH2 NOTCH3 OTOG | 1.85e-04 | 1285 | 66 | 13 | GO:0031175 |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 2.10e-04 | 7 | 66 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 2.10e-04 | 7 | 66 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | recognition of apoptotic cell | 2.10e-04 | 7 | 66 | 2 | GO:0043654 | |
| GeneOntologyBiologicalProcess | response to wounding | 2.39e-04 | 659 | 66 | 9 | GO:0009611 | |
| GeneOntologyBiologicalProcess | embryo implantation | 2.65e-04 | 97 | 66 | 4 | GO:0007566 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 2.86e-04 | 99 | 66 | 4 | GO:0045995 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.16e-04 | 185 | 66 | 5 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.16e-04 | 185 | 66 | 5 | GO:0035108 | |
| GeneOntologyBiologicalProcess | positive regulation of BMP signaling pathway | 3.29e-04 | 42 | 66 | 3 | GO:0030513 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 3.40e-04 | 412 | 66 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | response to growth factor | 4.70e-04 | 883 | 66 | 10 | GO:0070848 | |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 5.44e-04 | 11 | 66 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 5.62e-04 | 321 | 66 | 6 | GO:0010001 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 6.02e-04 | 748 | 66 | 9 | GO:0048667 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 6.13e-04 | 750 | 66 | 9 | GO:0048729 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | JAG2 HSPG2 FRAS1 ERBB4 FBN2 MEGF8 TNC LAMA2 LAMA3 LAMA5 NOTCH2 CRB2 | 6.23e-04 | 1269 | 66 | 12 | GO:0009887 |
| GeneOntologyBiologicalProcess | base-excision repair, AP site formation | 6.52e-04 | 12 | 66 | 2 | GO:0006285 | |
| GeneOntologyBiologicalProcess | skeletal system development | 7.48e-04 | 615 | 66 | 8 | GO:0001501 | |
| GeneOntologyBiologicalProcess | limb development | 7.54e-04 | 224 | 66 | 5 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 7.54e-04 | 224 | 66 | 5 | GO:0048736 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 7.80e-04 | 619 | 66 | 8 | GO:0002009 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 8.95e-04 | 14 | 66 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 9.87e-04 | 802 | 66 | 9 | GO:0048812 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.08e-03 | 63 | 66 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.14e-03 | 819 | 66 | 9 | GO:0120039 | |
| GeneOntologyBiologicalProcess | kidney development | 1.21e-03 | 372 | 66 | 6 | GO:0001822 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.21e-03 | 826 | 66 | 9 | GO:0048858 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | 1.25e-03 | 514 | 66 | 7 | GO:0050678 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.26e-03 | 1186 | 66 | 11 | GO:0007167 | |
| GeneOntologyBiologicalProcess | regeneration | 1.27e-03 | 252 | 66 | 5 | GO:0031099 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | HSPG2 ERBB3 ERBB4 TNC NCAN GRN ZP4 CDH3 MEGF10 NOTCH2 NOTCH3 | 1.30e-03 | 1190 | 66 | 11 | GO:0008284 |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 1.30e-03 | 148 | 66 | 4 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 1.30e-03 | 148 | 66 | 4 | GO:0035113 | |
| GeneOntologyBiologicalProcess | positive regulation of axon regeneration | 1.33e-03 | 17 | 66 | 2 | GO:0048680 | |
| GeneOntologyBiologicalProcess | axon regeneration | 1.41e-03 | 69 | 66 | 3 | GO:0031103 | |
| GeneOntologyBiologicalProcess | renal system development | 1.46e-03 | 386 | 66 | 6 | GO:0072001 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.48e-03 | 850 | 66 | 9 | GO:0071363 | |
| GeneOntologyBiologicalProcess | positive regulation of keratinocyte proliferation | 1.49e-03 | 18 | 66 | 2 | GO:0010838 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection regeneration | 1.49e-03 | 18 | 66 | 2 | GO:0070572 | |
| GeneOntologyCellularComponent | extracellular matrix | CRISPLD2 TRIL VWC2 HSPG2 LAMB4 FRAS1 THBS2 FBN2 VWF TNC NCAN LAMA2 LAMA3 LAMA5 ZP4 SSPOP MUC6 OTOG | 8.70e-13 | 656 | 65 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | CRISPLD2 TRIL VWC2 HSPG2 LAMB4 FRAS1 THBS2 FBN2 VWF TNC NCAN LAMA2 LAMA3 LAMA5 ZP4 SSPOP MUC6 OTOG | 9.16e-13 | 658 | 65 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 1.41e-10 | 122 | 65 | 9 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | VWC2 HSPG2 LAMB4 FRAS1 THBS2 FBN2 VWF TNC NCAN LAMA2 LAMA3 LAMA5 ZP4 SSPOP | 7.13e-10 | 530 | 65 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 8.03e-06 | 13 | 65 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.26e-05 | 109 | 65 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | laminin-5 complex | 5.69e-05 | 4 | 65 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | laminin complex | 4.22e-04 | 10 | 65 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | receptor complex | 4.25e-04 | 581 | 65 | 8 | GO:0043235 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 5.14e-04 | 11 | 65 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 6.89e-04 | 785 | 65 | 9 | GO:0098797 | |
| GeneOntologyCellularComponent | interstitial matrix | 1.26e-03 | 17 | 65 | 2 | GO:0005614 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.26e-03 | 17 | 65 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | keratin filament | 3.44e-03 | 97 | 65 | 3 | GO:0045095 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 3.92e-03 | 30 | 65 | 2 | GO:0032281 | |
| GeneOntologyCellularComponent | phagocytic cup | 4.18e-03 | 31 | 65 | 2 | GO:0001891 | |
| GeneOntologyCellularComponent | synaptic cleft | 4.72e-03 | 33 | 65 | 2 | GO:0043083 | |
| GeneOntologyCellularComponent | neuromuscular junction | 5.14e-03 | 112 | 65 | 3 | GO:0031594 | |
| MousePheno | abnormal basement membrane morphology | 1.30e-05 | 40 | 51 | 4 | MP:0004272 | |
| MousePheno | syndactyly | 2.16e-05 | 93 | 51 | 5 | MP:0000564 | |
| MousePheno | mesocardia | 4.99e-05 | 20 | 51 | 3 | MP:0000650 | |
| MousePheno | abnormal digit development | 7.70e-05 | 23 | 51 | 3 | MP:0006280 | |
| MousePheno | abnormal ophthalmic nerve morphology | 7.79e-05 | 4 | 51 | 2 | MP:0009798 | |
| MousePheno | abnormal interdigital cell death | 1.30e-04 | 5 | 51 | 2 | MP:0009874 | |
| MousePheno | abnormal limb development | 1.52e-04 | 140 | 51 | 5 | MP:0006279 | |
| MousePheno | abnormal glial cell morphology | 2.39e-04 | 345 | 51 | 7 | MP:0003634 | |
| MousePheno | abnormal locomotor coordination | 2.47e-04 | 726 | 51 | 10 | MP:0003312 | |
| MousePheno | abnormal appendicular skeleton morphology | JAG2 TPO PCSK5 HSPG2 FRAS1 FBN2 MEGF8 SCARF2 MED25 SSPOP NOTCH2 | 3.14e-04 | 896 | 51 | 11 | MP:0009250 |
| MousePheno | abnormal Schwann cell morphology | 3.26e-04 | 37 | 51 | 3 | MP:0001106 | |
| MousePheno | abnormal PNS glial cell morphology | 3.26e-04 | 37 | 51 | 3 | MP:0001105 | |
| Domain | EGF-like_dom | SCARF1 JAG2 TPO PCSK5 ATRN HSPG2 FRAS1 THBS2 FBN2 PROZ MEGF8 TIE1 SCARF2 TNC NCAN DNER LAMA2 LAMA3 LAMA5 NAGPA VWDE MEGF10 NOTCH2 NOTCH3 CRB2 MASP2 OTOG PEAR1 | 1.46e-35 | 249 | 66 | 28 | IPR000742 |
| Domain | EGF | SCARF1 JAG2 TPO PCSK5 ATRN HSPG2 FRAS1 THBS2 FBN2 PROZ MEGF8 TIE1 SCARF2 TNC NCAN DNER LAMA2 LAMA3 LAMA5 NAGPA VWDE MEGF10 NOTCH2 NOTCH3 CRB2 MASP2 PEAR1 | 1.71e-34 | 235 | 66 | 27 | SM00181 |
| Domain | EGF_1 | SCARF1 JAG2 TPO ATRN HSPG2 LAMB4 THBS2 FBN2 PROZ MEGF8 TIE1 SCARF2 TNC NCAN DNER LAMA2 LAMA3 LAMA5 NAGPA SSPOP VWDE MEGF10 NOTCH2 NOTCH3 CRB2 MASP2 PEAR1 | 1.69e-33 | 255 | 66 | 27 | PS00022 |
| Domain | EGF_2 | SCARF1 JAG2 TPO ATRN HSPG2 LAMB4 THBS2 FBN2 PROZ MEGF8 TIE1 SCARF2 TNC NCAN DNER LAMA2 LAMA3 LAMA5 NAGPA SSPOP VWDE MEGF10 NOTCH2 NOTCH3 CRB2 MASP2 PEAR1 | 4.95e-33 | 265 | 66 | 27 | PS01186 |
| Domain | EGF-like_CS | SCARF1 JAG2 TPO ATRN HSPG2 LAMB4 THBS2 FBN2 PROZ MEGF8 TIE1 SCARF2 TNC NCAN DNER LAMA2 LAMA3 LAMA5 NAGPA VWDE MEGF10 NOTCH2 NOTCH3 CRB2 MASP2 PEAR1 | 1.71e-31 | 261 | 66 | 26 | IPR013032 |
| Domain | EGF_3 | SCARF1 JAG2 TPO ATRN HSPG2 THBS2 FBN2 PROZ MEGF8 TIE1 SCARF2 TNC NCAN DNER NAGPA SSPOP VWDE MEGF10 NOTCH2 NOTCH3 CRB2 MASP2 OTOG PEAR1 | 2.94e-29 | 235 | 66 | 24 | PS50026 |
| Domain | Growth_fac_rcpt_ | SCARF1 JAG2 PCSK5 ATRN HSPG2 FRAS1 ERBB3 ERBB4 FBN2 MEGF8 TIE1 SCARF2 TNC DNER LAMA3 LAMA5 NOTCH2 NOTCH3 | 6.96e-23 | 156 | 66 | 18 | IPR009030 |
| Domain | Laminin_EGF | SCARF1 ATRN HSPG2 LAMB4 MEGF8 SCARF2 LAMA2 LAMA3 LAMA5 MEGF10 PEAR1 | 1.74e-19 | 35 | 66 | 11 | PF00053 |
| Domain | Laminin_EGF | SCARF1 ATRN HSPG2 LAMB4 MEGF8 SCARF2 LAMA2 LAMA3 LAMA5 MEGF10 PEAR1 | 4.99e-19 | 38 | 66 | 11 | IPR002049 |
| Domain | EGF_Lam | ATRN HSPG2 LAMB4 MEGF8 SCARF2 LAMA2 LAMA3 LAMA5 MEGF10 PEAR1 | 2.55e-17 | 35 | 66 | 10 | SM00180 |
| Domain | VWF_dom | 2.00e-16 | 42 | 66 | 10 | IPR001007 | |
| Domain | EGF_CA | JAG2 TPO HSPG2 THBS2 FBN2 PROZ MEGF8 NCAN DNER NOTCH2 NOTCH3 CRB2 MASP2 | 3.13e-16 | 122 | 66 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | JAG2 TPO HSPG2 THBS2 FBN2 PROZ MEGF8 NCAN DNER NOTCH2 NOTCH3 CRB2 MASP2 | 3.89e-16 | 124 | 66 | 13 | IPR001881 |
| Domain | EGF | JAG2 ATRN HSPG2 THBS2 PROZ TIE1 TNC NCAN DNER NAGPA NOTCH2 NOTCH3 CRB2 | 4.81e-16 | 126 | 66 | 13 | PF00008 |
| Domain | EGF_extracell | 9.77e-15 | 60 | 66 | 10 | IPR013111 | |
| Domain | EGF_2 | 9.77e-15 | 60 | 66 | 10 | PF07974 | |
| Domain | ASX_HYDROXYL | 4.96e-14 | 100 | 66 | 11 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.58e-14 | 106 | 66 | 11 | IPR000152 | |
| Domain | VWC_out | 2.42e-13 | 19 | 66 | 7 | SM00215 | |
| Domain | VWFC_1 | 4.39e-13 | 36 | 66 | 8 | PS01208 | |
| Domain | VWC | 7.05e-13 | 38 | 66 | 8 | SM00214 | |
| Domain | VWFC_2 | 7.05e-13 | 38 | 66 | 8 | PS50184 | |
| Domain | EGF_Ca-bd_CS | 1.47e-12 | 97 | 66 | 10 | IPR018097 | |
| Domain | EGF_CA | 1.81e-12 | 99 | 66 | 10 | PS01187 | |
| Domain | hEGF | 5.54e-12 | 28 | 66 | 7 | PF12661 | |
| Domain | EGF_LAM_2 | 9.47e-12 | 30 | 66 | 7 | PS50027 | |
| Domain | EGF_LAM_1 | 9.47e-12 | 30 | 66 | 7 | PS01248 | |
| Domain | VWD | 1.20e-11 | 16 | 66 | 6 | SM00216 | |
| Domain | VWF_type-D | 1.20e-11 | 16 | 66 | 6 | IPR001846 | |
| Domain | VWFD | 1.20e-11 | 16 | 66 | 6 | PS51233 | |
| Domain | VWD | 1.20e-11 | 16 | 66 | 6 | PF00094 | |
| Domain | Unchr_dom_Cys-rich | 5.95e-10 | 13 | 66 | 5 | IPR014853 | |
| Domain | C8 | 5.95e-10 | 13 | 66 | 5 | SM00832 | |
| Domain | EGF_CA | 6.70e-10 | 86 | 66 | 8 | PF07645 | |
| Domain | TIL_dom | 9.22e-10 | 14 | 66 | 5 | IPR002919 | |
| Domain | LAMININ_IVA | 9.85e-09 | 8 | 66 | 4 | PS51115 | |
| Domain | Laminin_B | 9.85e-09 | 8 | 66 | 4 | PF00052 | |
| Domain | LamB | 9.85e-09 | 8 | 66 | 4 | SM00281 | |
| Domain | Laminin_IV | 9.85e-09 | 8 | 66 | 4 | IPR000034 | |
| Domain | VWC | 4.36e-08 | 28 | 66 | 5 | PF00093 | |
| Domain | Laminin_G | 5.41e-08 | 58 | 66 | 6 | IPR001791 | |
| Domain | TIL | 6.89e-08 | 12 | 66 | 4 | PF01826 | |
| Domain | C8 | 6.89e-08 | 12 | 66 | 4 | PF08742 | |
| Domain | LAM_G_DOMAIN | 2.17e-07 | 38 | 66 | 5 | PS50025 | |
| Domain | Laminin_N | 2.51e-07 | 16 | 66 | 4 | IPR008211 | |
| Domain | LAMININ_NTER | 2.51e-07 | 16 | 66 | 4 | PS51117 | |
| Domain | Laminin_N | 2.51e-07 | 16 | 66 | 4 | PF00055 | |
| Domain | LamNT | 2.51e-07 | 16 | 66 | 4 | SM00136 | |
| Domain | Laminin_G_2 | 2.82e-07 | 40 | 66 | 5 | PF02210 | |
| Domain | Furin_repeat | 4.19e-07 | 18 | 66 | 4 | IPR006212 | |
| Domain | FU | 4.19e-07 | 18 | 66 | 4 | SM00261 | |
| Domain | Laminin_aI | 4.19e-07 | 5 | 66 | 3 | IPR009254 | |
| Domain | Laminin_I | 4.19e-07 | 5 | 66 | 3 | PF06008 | |
| Domain | Laminin_II | 4.19e-07 | 5 | 66 | 3 | PF06009 | |
| Domain | Laminin_domII | 4.19e-07 | 5 | 66 | 3 | IPR010307 | |
| Domain | LamG | 4.61e-07 | 44 | 66 | 5 | SM00282 | |
| Domain | GF_recep_IV | 8.37e-07 | 6 | 66 | 3 | PF14843 | |
| Domain | GF_recep_IV | 8.37e-07 | 6 | 66 | 3 | IPR032778 | |
| Domain | - | 1.05e-06 | 95 | 66 | 6 | 2.60.120.200 | |
| Domain | Cys_knot_C | 1.70e-06 | 25 | 66 | 4 | IPR006207 | |
| Domain | CTCK_2 | 1.70e-06 | 25 | 66 | 4 | PS01225 | |
| Domain | ConA-like_dom | 1.20e-05 | 219 | 66 | 7 | IPR013320 | |
| Domain | EMI | 2.77e-05 | 17 | 66 | 3 | PS51041 | |
| Domain | DUF3454 | 3.68e-05 | 3 | 66 | 2 | PF11936 | |
| Domain | DUF3454_notch | 3.68e-05 | 3 | 66 | 2 | IPR024600 | |
| Domain | DUF3454 | 3.68e-05 | 3 | 66 | 2 | SM01334 | |
| Domain | CT | 6.19e-05 | 22 | 66 | 3 | SM00041 | |
| Domain | Notch | 7.35e-05 | 4 | 66 | 2 | IPR008297 | |
| Domain | NODP | 7.35e-05 | 4 | 66 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 7.35e-05 | 4 | 66 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 7.35e-05 | 4 | 66 | 2 | IPR010660 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 7.35e-05 | 4 | 66 | 2 | IPR016245 | |
| Domain | NOD | 7.35e-05 | 4 | 66 | 2 | PF06816 | |
| Domain | NOD | 7.35e-05 | 4 | 66 | 2 | SM01338 | |
| Domain | NODP | 7.35e-05 | 4 | 66 | 2 | SM01339 | |
| Domain | LNR | 1.22e-04 | 5 | 66 | 2 | PS50258 | |
| Domain | Furin-like | 2.55e-04 | 7 | 66 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 2.55e-04 | 7 | 66 | 2 | IPR000494 | |
| Domain | Znf_GRF | 2.55e-04 | 7 | 66 | 2 | IPR010666 | |
| Domain | Notch_dom | 2.55e-04 | 7 | 66 | 2 | IPR000800 | |
| Domain | zf-GRF | 2.55e-04 | 7 | 66 | 2 | PF06839 | |
| Domain | Furin-like_Cys-rich_dom | 2.55e-04 | 7 | 66 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 2.55e-04 | 7 | 66 | 2 | PF01030 | |
| Domain | Notch | 2.55e-04 | 7 | 66 | 2 | PF00066 | |
| Domain | - | 2.55e-04 | 7 | 66 | 2 | 3.80.20.20 | |
| Domain | NL | 2.55e-04 | 7 | 66 | 2 | SM00004 | |
| Domain | Galactose-bd-like | 3.42e-04 | 94 | 66 | 4 | IPR008979 | |
| Domain | Laminin_G_1 | 6.63e-04 | 11 | 66 | 2 | PF00054 | |
| Domain | CUB | 6.91e-04 | 49 | 66 | 3 | PF00431 | |
| Domain | CUB | 7.34e-04 | 50 | 66 | 3 | SM00042 | |
| Domain | EGF_3 | 7.93e-04 | 12 | 66 | 2 | PF12947 | |
| Domain | EGF_dom | 7.93e-04 | 12 | 66 | 2 | IPR024731 | |
| Domain | - | 8.23e-04 | 52 | 66 | 3 | 2.60.120.290 | |
| Domain | Sushi | 8.23e-04 | 52 | 66 | 3 | PF00084 | |
| Domain | CUB | 8.70e-04 | 53 | 66 | 3 | PS01180 | |
| Domain | CCP | 9.19e-04 | 54 | 66 | 3 | SM00032 | |
| Domain | SUSHI | 1.02e-03 | 56 | 66 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.08e-03 | 57 | 66 | 3 | IPR000436 | |
| Domain | CUB_dom | 1.08e-03 | 57 | 66 | 3 | IPR000859 | |
| Domain | KAP | 1.13e-03 | 58 | 66 | 3 | IPR002494 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.52e-10 | 84 | 48 | 8 | M7098 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.06e-07 | 76 | 48 | 6 | M27219 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.96e-07 | 143 | 48 | 7 | M27275 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.61e-06 | 59 | 48 | 5 | M27218 | |
| Pathway | PID_NOTCH_PATHWAY | 1.61e-06 | 59 | 48 | 5 | M17 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.96e-06 | 27 | 48 | 4 | M39545 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.83e-06 | 66 | 48 | 5 | M18 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.04e-06 | 30 | 48 | 4 | M27216 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.28e-06 | 68 | 48 | 5 | M27303 | |
| Pathway | KEGG_FOCAL_ADHESION | 4.53e-06 | 199 | 48 | 7 | M7253 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 6.00e-06 | 11 | 48 | 3 | M158 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.90e-06 | 300 | 48 | 8 | M610 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.03e-05 | 13 | 48 | 3 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.03e-05 | 13 | 48 | 3 | M47534 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.74e-05 | 46 | 48 | 4 | M239 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.01e-05 | 250 | 48 | 7 | M27554 | |
| Pathway | WP_FOCAL_ADHESION | 3.88e-05 | 187 | 48 | 6 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 5.50e-05 | 199 | 48 | 6 | M39402 | |
| Pathway | REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR | 1.13e-04 | 5 | 48 | 2 | M29801 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.13e-04 | 5 | 48 | 2 | M27411 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.38e-04 | 339 | 48 | 7 | M39736 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.41e-04 | 30 | 48 | 3 | M27772 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.69e-04 | 6 | 48 | 2 | M27068 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.87e-04 | 84 | 48 | 4 | M3228 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.88e-04 | 33 | 48 | 3 | M39503 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 3.12e-04 | 96 | 48 | 4 | M39834 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.61e-04 | 41 | 48 | 3 | M27778 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 4.76e-04 | 45 | 48 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 5.07e-04 | 46 | 48 | 3 | MM15971 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.29e-04 | 302 | 48 | 6 | M39719 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 5.41e-04 | 47 | 48 | 3 | M7946 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 6.12e-04 | 11 | 48 | 2 | M47865 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 6.12e-04 | 11 | 48 | 2 | MM15478 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 7.33e-04 | 12 | 48 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 7.33e-04 | 12 | 48 | 2 | M47533 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 7.91e-04 | 326 | 48 | 6 | MM15917 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 8.65e-04 | 13 | 48 | 2 | M27729 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 8.65e-04 | 13 | 48 | 2 | MM15320 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 1.01e-03 | 14 | 48 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 1.01e-03 | 14 | 48 | 2 | MM14531 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 1.16e-03 | 15 | 48 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 1.16e-03 | 15 | 48 | 2 | M27608 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.16e-03 | 61 | 48 | 3 | M39540 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.29e-03 | 140 | 48 | 4 | M587 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 1.32e-03 | 16 | 48 | 2 | M570 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.46e-03 | 66 | 48 | 3 | MM15925 | |
| Pathway | WP_CANCER_PATHWAYS | 1.53e-03 | 507 | 48 | 7 | M48302 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.68e-03 | 18 | 48 | 2 | M614 | |
| Pathway | WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS | 1.87e-03 | 19 | 48 | 2 | M39473 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.87e-03 | 19 | 48 | 2 | MM15594 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.01e-03 | 532 | 48 | 7 | M27870 | |
| Pathway | REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE | 2.07e-03 | 20 | 48 | 2 | M27258 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.44e-03 | 79 | 48 | 3 | M27643 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.51e-03 | 22 | 48 | 2 | M27210 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 2.51e-03 | 22 | 48 | 2 | M26929 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.72e-03 | 82 | 48 | 3 | MM15922 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 2.74e-03 | 23 | 48 | 2 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 2.74e-03 | 23 | 48 | 2 | M18719 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 2.99e-03 | 24 | 48 | 2 | M11190 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.01e-03 | 85 | 48 | 3 | M16441 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.24e-03 | 25 | 48 | 2 | M27879 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 3.24e-03 | 25 | 48 | 2 | M47934 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 3.50e-03 | 26 | 48 | 2 | M29535 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 3.50e-03 | 26 | 48 | 2 | M708 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 3.50e-03 | 26 | 48 | 2 | MM15501 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 4.06e-03 | 28 | 48 | 2 | M6177 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 4.35e-03 | 29 | 48 | 2 | M27756 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 4.96e-03 | 31 | 48 | 2 | MM1343 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 4.96e-03 | 31 | 48 | 2 | M592 | |
| Pathway | WP_BASE_EXCISION_REPAIR | 4.96e-03 | 31 | 48 | 2 | M39861 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 5.28e-03 | 32 | 48 | 2 | M165 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 5.60e-03 | 33 | 48 | 2 | M39455 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 5.60e-03 | 33 | 48 | 2 | M6220 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 5.60e-03 | 33 | 48 | 2 | M604 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 5.60e-03 | 33 | 48 | 2 | MM14523 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 5.94e-03 | 34 | 48 | 2 | M39390 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.04e-03 | 109 | 48 | 3 | MM15164 | |
| Pathway | KEGG_BASE_EXCISION_REPAIR | 6.29e-03 | 35 | 48 | 2 | M5500 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.35e-03 | 111 | 48 | 3 | M27416 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 7.38e-03 | 38 | 48 | 2 | MM15434 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 7.52e-03 | 118 | 48 | 3 | M39852 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 7.76e-03 | 39 | 48 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 7.76e-03 | 39 | 48 | 2 | MM15165 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 7.76e-03 | 39 | 48 | 2 | MM14604 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.06e-10 | 79 | 68 | 7 | 18757743 | |
| Pubmed | 2.00e-09 | 175 | 68 | 8 | 28071719 | ||
| Pubmed | 2.82e-09 | 29 | 68 | 5 | 22613833 | ||
| Pubmed | 6.54e-09 | 12 | 68 | 4 | 16750824 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 9.03e-09 | 135 | 68 | 7 | 28675934 | |
| Pubmed | 1.56e-08 | 146 | 68 | 7 | 27068509 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.79e-08 | 15 | 68 | 4 | 15895400 | |
| Pubmed | 3.93e-08 | 167 | 68 | 7 | 22159717 | ||
| Pubmed | 4.01e-08 | 18 | 68 | 4 | 11311202 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 11969289 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 7.13e-08 | 5 | 68 | 3 | 15064243 | |
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 7.13e-08 | 5 | 68 | 3 | 9415429 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 16899352 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 11829758 | ||
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 7.13e-08 | 5 | 68 | 3 | 9389447 | |
| Pubmed | 1.24e-07 | 118 | 68 | 6 | 21078624 | ||
| Pubmed | 1.42e-07 | 6 | 68 | 3 | 9597096 | ||
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 1.64e-07 | 25 | 68 | 4 | 19373938 | |
| Pubmed | 1.72e-07 | 64 | 68 | 5 | 22261194 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.93e-07 | 26 | 68 | 4 | 34189436 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | JAG2 PCSK5 HSPG2 FRAS1 MEGF8 ZNF316 NFX1 ZNF398 LAMA5 DGKQ UNKL CEP192 NOTCH2 | 1.94e-07 | 1105 | 68 | 13 | 35748872 |
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 10383933 | ||
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 2.49e-07 | 7 | 68 | 3 | 12846471 | |
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 16169548 | ||
| Pubmed | 2.90e-07 | 71 | 68 | 5 | 33541421 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 3.98e-07 | 8 | 68 | 3 | 22652674 | |
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 9852162 | ||
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 8872465 | ||
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 9858718 | ||
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 11044610 | ||
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 4.04e-07 | 31 | 68 | 4 | 31550482 | |
| Pubmed | 4.04e-07 | 31 | 68 | 4 | 22274697 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 5.77e-07 | 248 | 68 | 7 | 24006456 | |
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 11118901 | ||
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 16245338 | ||
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 9882526 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 8.49e-07 | 10 | 68 | 3 | 23665443 | |
| Pubmed | 8.49e-07 | 10 | 68 | 3 | 9034910 | ||
| Pubmed | 8.62e-07 | 164 | 68 | 6 | 32409323 | ||
| Pubmed | 1.16e-06 | 40 | 68 | 4 | 27068110 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.17e-06 | 11 | 68 | 3 | 38303699 | |
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 1.17e-06 | 11 | 68 | 3 | 16607638 | |
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 12051813 | ||
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 10878608 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.17e-06 | 11 | 68 | 3 | 21524702 | |
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 12866128 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 1.45e-06 | 560 | 68 | 9 | 21653829 | |
| Pubmed | 1.55e-06 | 12 | 68 | 3 | 15465494 | ||
| Pubmed | 1.55e-06 | 12 | 68 | 3 | 9396756 | ||
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 2.02e-06 | 13 | 68 | 3 | 31202705 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 2.02e-06 | 13 | 68 | 3 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 2.02e-06 | 13 | 68 | 3 | 20558824 | |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 2.02e-06 | 13 | 68 | 3 | 36335435 | |
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 2.02e-06 | 13 | 68 | 3 | 21900571 | |
| Pubmed | 2.56e-06 | 14 | 68 | 3 | 9151674 | ||
| Pubmed | 2.56e-06 | 14 | 68 | 3 | 14757642 | ||
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 2.88e-06 | 50 | 68 | 4 | 24191021 | |
| Pubmed | 2.88e-06 | 50 | 68 | 4 | 23658023 | ||
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 17194759 | ||
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 12971992 | ||
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 9291577 | ||
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 9264260 | ||
| Pubmed | Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. | 3.20e-06 | 15 | 68 | 3 | 12167404 | |
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 3.20e-06 | 15 | 68 | 3 | 16914494 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | JAG2 ATRN HSPG2 FRAS1 FBN2 MEGF8 DNER LAMA5 GRN NAGPA NOTCH2 NOTCH3 | 3.32e-06 | 1201 | 68 | 12 | 35696571 |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 8939648 | ||
| Pubmed | Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. | 3.77e-06 | 2 | 68 | 2 | 18182100 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16226104 | ||
| Pubmed | Expression of notch family proteins in placentas from patients with early-onset severe preeclampsia. | 3.77e-06 | 2 | 68 | 2 | 24336671 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 27536774 | ||
| Pubmed | Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling. | 3.77e-06 | 2 | 68 | 2 | 26745281 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12382139 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 34257585 | ||
| Pubmed | Biological function of laminin-5 and pathogenic impact of its deficiency. | 3.77e-06 | 2 | 68 | 2 | 17000025 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12900424 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 31400925 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12931033 | ||
| Pubmed | The upgraded role of HER3 and HER4 receptors in breast cancer. | 3.77e-06 | 2 | 68 | 2 | 19481955 | |
| Pubmed | Effects of Notch2 and Notch3 on Cell Proliferation and Apoptosis of Trophoblast Cell Lines. | 3.77e-06 | 2 | 68 | 2 | 26640406 | |
| Pubmed | Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients. | 3.77e-06 | 2 | 68 | 2 | 26254096 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 28851073 | ||
| Pubmed | Mapping of a defined neurocan binding site to distinct domains of tenascin-C. | 3.77e-06 | 2 | 68 | 2 | 9341124 | |
| Pubmed | Notch2 and Notch3 function together to regulate vascular smooth muscle development. | 3.77e-06 | 2 | 68 | 2 | 22615991 | |
| Pubmed | Fibrillin-2 and Tenascin-C bridge the age gap in lung epithelial regeneration. | 3.77e-06 | 2 | 68 | 2 | 28662401 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17969526 | ||
| Pubmed | Association of vWA and TPOX polymorphisms with venous thrombosis in Mexican mestizos. | 3.77e-06 | 2 | 68 | 2 | 25250329 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19390858 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12496659 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12154095 | ||
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 3.78e-06 | 630 | 68 | 9 | 36949045 | |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 3.93e-06 | 16 | 68 | 3 | 12617809 | |
| Pubmed | 3.93e-06 | 16 | 68 | 3 | 17601529 | ||
| Pubmed | 3.93e-06 | 16 | 68 | 3 | 10842072 | ||
| Pubmed | 3.93e-06 | 16 | 68 | 3 | 17273555 | ||
| Pubmed | The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. | 3.93e-06 | 16 | 68 | 3 | 27641601 | |
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 3.93e-06 | 16 | 68 | 3 | 21067603 | |
| Pubmed | 3.93e-06 | 16 | 68 | 3 | 32161758 | ||
| Pubmed | 3.93e-06 | 16 | 68 | 3 | 16880404 | ||
| Pubmed | 4.77e-06 | 17 | 68 | 3 | 18694942 | ||
| Interaction | IGFL3 interactions | JAG2 PCSK5 ATRN FRAS1 FBN2 LAMA3 LAMA5 GRN VWDE NOTCH2 NOTCH3 | 8.05e-16 | 75 | 66 | 11 | int:IGFL3 |
| Interaction | HOXA1 interactions | JAG2 PCSK5 VWC2 VWF MEGF8 KRTAP1-1 KRTAP1-3 VWC2L LAMA5 DGKQ UNKL GRN KRTAP26-1 NOTCH3 | 7.54e-12 | 356 | 66 | 14 | int:HOXA1 |
| Interaction | NTN5 interactions | 1.26e-10 | 24 | 66 | 6 | int:NTN5 | |
| Interaction | MFAP5 interactions | 3.47e-10 | 52 | 66 | 7 | int:MFAP5 | |
| Interaction | LYPD1 interactions | 7.68e-10 | 58 | 66 | 7 | int:LYPD1 | |
| Interaction | FBXO2 interactions | JAG2 PCSK5 ATRN HSPG2 FRAS1 FBN2 MEGF8 LAMA3 LAMA5 GRN NOTCH2 NOTCH3 | 8.04e-09 | 411 | 66 | 12 | int:FBXO2 |
| Interaction | ZNF408 interactions | 2.39e-08 | 145 | 66 | 8 | int:ZNF408 | |
| Interaction | EDN3 interactions | 6.26e-08 | 108 | 66 | 7 | int:EDN3 | |
| Interaction | PRG2 interactions | 3.65e-07 | 285 | 66 | 9 | int:PRG2 | |
| Interaction | SIRPD interactions | 3.75e-07 | 86 | 66 | 6 | int:SIRPD | |
| Interaction | SLURP1 interactions | 4.50e-07 | 144 | 66 | 7 | int:SLURP1 | |
| Interaction | KRTAP10-8 interactions | SCARF1 PCSK5 VWC2 TIE1 KRTAP1-1 KRTAP1-3 VWC2L GRN KRTAP26-1 FBXO34 | 6.80e-07 | 401 | 66 | 10 | int:KRTAP10-8 |
| Interaction | OTX1 interactions | 7.40e-07 | 155 | 66 | 7 | int:OTX1 | |
| Interaction | VASN interactions | 9.16e-07 | 160 | 66 | 7 | int:VASN | |
| Interaction | SDF2L1 interactions | 1.01e-06 | 322 | 66 | 9 | int:SDF2L1 | |
| Interaction | ZFP41 interactions | 1.19e-06 | 57 | 66 | 5 | int:ZFP41 | |
| Interaction | CXCL5 interactions | 1.74e-06 | 27 | 66 | 4 | int:CXCL5 | |
| Interaction | ZNF696 interactions | 2.87e-06 | 68 | 66 | 5 | int:ZNF696 | |
| Interaction | CACNA1A interactions | 3.08e-06 | 123 | 66 | 6 | int:CACNA1A | |
| Interaction | LCE1D interactions | 3.32e-06 | 70 | 66 | 5 | int:LCE1D | |
| Interaction | CFC1 interactions | 3.54e-06 | 126 | 66 | 6 | int:CFC1 | |
| Interaction | LCE3D interactions | 4.08e-06 | 73 | 66 | 5 | int:LCE3D | |
| Interaction | LCE3A interactions | 4.98e-06 | 76 | 66 | 5 | int:LCE3A | |
| Interaction | ST14 interactions | 5.08e-06 | 207 | 66 | 7 | int:ST14 | |
| Interaction | LCE1A interactions | 8.16e-06 | 84 | 66 | 5 | int:LCE1A | |
| Interaction | NID2 interactions | 9.16e-06 | 86 | 66 | 5 | int:NID2 | |
| Interaction | LCE5A interactions | 1.14e-05 | 90 | 66 | 5 | int:LCE5A | |
| Interaction | LGALS1 interactions | 1.25e-05 | 332 | 66 | 8 | int:LGALS1 | |
| Interaction | ELSPBP1 interactions | 1.27e-05 | 92 | 66 | 5 | int:ELSPBP1 | |
| Interaction | ZNF497 interactions | 1.29e-05 | 44 | 66 | 4 | int:ZNF497 | |
| Interaction | PRG3 interactions | 1.99e-05 | 49 | 66 | 4 | int:PRG3 | |
| Interaction | FBN1 interactions | 2.33e-05 | 51 | 66 | 4 | int:FBN1 | |
| Interaction | PTPRK interactions | 2.48e-05 | 177 | 66 | 6 | int:PTPRK | |
| Interaction | TYW3 interactions | 2.72e-05 | 53 | 66 | 4 | int:TYW3 | |
| Interaction | ATN1 interactions | 3.37e-05 | 187 | 66 | 6 | int:ATN1 | |
| Interaction | MAML3 interactions | 3.68e-05 | 20 | 66 | 3 | int:MAML3 | |
| Interaction | CYSRT1 interactions | SCARF1 PCSK5 VWC2 KRTAP1-1 KRTAP1-3 MED25 VWC2L GRN KRTAP26-1 | 4.14e-05 | 511 | 66 | 9 | int:CYSRT1 |
| Interaction | CEACAM8 interactions | 4.42e-05 | 119 | 66 | 5 | int:CEACAM8 | |
| Interaction | LCE3E interactions | 4.46e-05 | 60 | 66 | 4 | int:LCE3E | |
| Interaction | ALPP interactions | 5.18e-05 | 123 | 66 | 5 | int:ALPP | |
| Interaction | IL5RA interactions | 5.38e-05 | 124 | 66 | 5 | int:IL5RA | |
| Interaction | KRTAP12-1 interactions | 5.40e-05 | 63 | 66 | 4 | int:KRTAP12-1 | |
| Interaction | ZDHHC15 interactions | 5.59e-05 | 125 | 66 | 5 | int:ZDHHC15 | |
| Interaction | OIT3 interactions | 6.11e-05 | 65 | 66 | 4 | int:OIT3 | |
| Interaction | SCARF2 interactions | 6.46e-05 | 24 | 66 | 3 | int:SCARF2 | |
| Interaction | FBLN2 interactions | 6.49e-05 | 66 | 66 | 4 | int:FBLN2 | |
| Interaction | LCE3C interactions | 6.89e-05 | 67 | 66 | 4 | int:LCE3C | |
| Interaction | NOTCH2 interactions | 6.98e-05 | 423 | 66 | 8 | int:NOTCH2 | |
| Interaction | SCARF1 interactions | 9.28e-05 | 27 | 66 | 3 | int:SCARF1 | |
| Interaction | LCE2D interactions | 1.02e-04 | 74 | 66 | 4 | int:LCE2D | |
| Interaction | FBXO6 interactions | 1.06e-04 | 717 | 66 | 10 | int:FBXO6 | |
| Interaction | KRTAP4-5 interactions | 1.13e-04 | 76 | 66 | 4 | int:KRTAP4-5 | |
| Interaction | MBD1 interactions | 1.19e-04 | 77 | 66 | 4 | int:MBD1 | |
| Interaction | EGFL7 interactions | 1.19e-04 | 77 | 66 | 4 | int:EGFL7 | |
| Interaction | ZNF707 interactions | 1.31e-04 | 79 | 66 | 4 | int:ZNF707 | |
| Interaction | SMCP interactions | 1.31e-04 | 79 | 66 | 4 | int:SMCP | |
| Interaction | ZNF837 interactions | 1.31e-04 | 79 | 66 | 4 | int:ZNF837 | |
| Interaction | LCE4A interactions | 1.38e-04 | 80 | 66 | 4 | int:LCE4A | |
| Interaction | LCE2B interactions | 1.44e-04 | 81 | 66 | 4 | int:LCE2B | |
| Interaction | PRELP interactions | 1.55e-04 | 32 | 66 | 3 | int:PRELP | |
| Interaction | POU4F2 interactions | 1.59e-04 | 83 | 66 | 4 | int:POU4F2 | |
| Interaction | MSTN interactions | 1.71e-04 | 33 | 66 | 3 | int:MSTN | |
| Interaction | KRTAP4-12 interactions | 1.84e-04 | 161 | 66 | 5 | int:KRTAP4-12 | |
| Interaction | LCE2C interactions | 1.99e-04 | 88 | 66 | 4 | int:LCE2C | |
| Interaction | KLK8 interactions | 2.04e-04 | 35 | 66 | 3 | int:KLK8 | |
| Interaction | NRG2 interactions | 2.19e-04 | 7 | 66 | 2 | int:NRG2 | |
| Interaction | LTBP1 interactions | 2.36e-04 | 92 | 66 | 4 | int:LTBP1 | |
| Interaction | LCE1F interactions | 2.36e-04 | 92 | 66 | 4 | int:LCE1F | |
| Interaction | TOP3B interactions | JAG2 PCSK5 HSPG2 FRAS1 MEGF8 ZNF316 NFX1 ZNF398 LAMA5 DGKQ UNKL GRN CEP192 NOTCH2 | 2.41e-04 | 1470 | 66 | 14 | int:TOP3B |
| Interaction | GREM2 interactions | 2.41e-04 | 37 | 66 | 3 | int:GREM2 | |
| Interaction | SHFL interactions | 2.89e-04 | 97 | 66 | 4 | int:SHFL | |
| Interaction | KRTAP13-2 interactions | 3.13e-04 | 99 | 66 | 4 | int:KRTAP13-2 | |
| Interaction | DEFA1 interactions | 3.25e-04 | 100 | 66 | 4 | int:DEFA1 | |
| Interaction | KRTAP9-8 interactions | 3.25e-04 | 100 | 66 | 4 | int:KRTAP9-8 | |
| Interaction | IGFBP4 interactions | 3.27e-04 | 41 | 66 | 3 | int:IGFBP4 | |
| Interaction | JAG1 interactions | 3.27e-04 | 41 | 66 | 3 | int:JAG1 | |
| Interaction | PSG8 interactions | 3.27e-04 | 41 | 66 | 3 | int:PSG8 | |
| Interaction | MUC4 interactions | 3.75e-04 | 9 | 66 | 2 | int:MUC4 | |
| Interaction | GNE interactions | 3.77e-04 | 104 | 66 | 4 | int:GNE | |
| Interaction | FGF4 interactions | 4.04e-04 | 44 | 66 | 3 | int:FGF4 | |
| Interaction | ZNF444 interactions | 4.06e-04 | 106 | 66 | 4 | int:ZNF444 | |
| Interaction | NUFIP2 interactions | 4.20e-04 | 417 | 66 | 7 | int:NUFIP2 | |
| Interaction | INHBE interactions | 4.31e-04 | 45 | 66 | 3 | int:INHBE | |
| Interaction | KRTAP11-1 interactions | 4.35e-04 | 108 | 66 | 4 | int:KRTAP11-1 | |
| Interaction | ATXN7 interactions | 4.51e-04 | 109 | 66 | 4 | int:ATXN7 | |
| Interaction | RASD1 interactions | 4.60e-04 | 46 | 66 | 3 | int:RASD1 | |
| Interaction | CMA1 interactions | 4.60e-04 | 46 | 66 | 3 | int:CMA1 | |
| Interaction | SPRY1 interactions | 4.83e-04 | 111 | 66 | 4 | int:SPRY1 | |
| Interaction | KRTAP5-9 interactions | 5.36e-04 | 203 | 66 | 5 | int:KRTAP5-9 | |
| Interaction | C22orf39 interactions | 5.55e-04 | 49 | 66 | 3 | int:C22orf39 | |
| Interaction | ZNF212 interactions | 5.55e-04 | 49 | 66 | 3 | int:ZNF212 | |
| Interaction | ZNF783 interactions | 5.70e-04 | 11 | 66 | 2 | int:ZNF783 | |
| Interaction | GLYAT interactions | 5.70e-04 | 11 | 66 | 2 | int:GLYAT | |
| Interaction | TAFAZZIN interactions | 5.86e-04 | 207 | 66 | 5 | int:TAFAZZIN | |
| Interaction | BCAM interactions | 5.89e-04 | 50 | 66 | 3 | int:BCAM | |
| Interaction | LYZL1 interactions | 6.08e-04 | 118 | 66 | 4 | int:LYZL1 | |
| Interaction | NCR3 interactions | 6.48e-04 | 120 | 66 | 4 | int:NCR3 | |
| Interaction | SLC16A8 interactions | 6.83e-04 | 12 | 66 | 2 | int:SLC16A8 | |
| Interaction | MFAP2 interactions | 6.83e-04 | 12 | 66 | 2 | int:MFAP2 | |
| Interaction | C17orf50 interactions | 6.83e-04 | 12 | 66 | 2 | int:C17orf50 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q34 | 2.05e-03 | 45 | 68 | 2 | chr2q34 | |
| GeneFamily | Laminin subunits | 1.49e-08 | 12 | 44 | 4 | 626 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 3.46e-05 | 4 | 44 | 2 | 1096 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 3.78e-05 | 27 | 44 | 3 | 1253 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 1.21e-04 | 7 | 44 | 2 | 135 | |
| GeneFamily | DNA glycosylases | 3.14e-04 | 11 | 44 | 2 | 1024 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.59e-04 | 57 | 44 | 3 | 1179 | |
| GeneFamily | Keratin associated proteins | 2.36e-03 | 109 | 44 | 3 | 619 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.47e-03 | 41 | 44 | 2 | 1298 | |
| GeneFamily | Fibronectin type III domain containing | 6.91e-03 | 160 | 44 | 3 | 555 | |
| Coexpression | NABA_CORE_MATRISOME | CRISPLD2 HSPG2 LAMB4 FRAS1 THBS2 FBN2 VWF TNC NCAN LAMA2 KCP LAMA3 LAMA5 ZP4 SSPOP VWDE OTOG | 3.83e-19 | 275 | 68 | 17 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | CRISPLD2 LAMB4 FRAS1 THBS2 FBN2 VWF TNC LAMA2 KCP LAMA3 LAMA5 ZP4 SSPOP VWDE OTOG | 2.33e-18 | 196 | 68 | 15 | M3008 |
| Coexpression | NABA_MATRISOME | TPO PCSK5 CRISPLD2 VWC2 HSPG2 LAMB4 FRAS1 THBS2 FBN2 VWF MEGF8 TNC NCAN VWC2L LAMA2 KCP LAMA3 LAMA5 ZP4 SSPOP MUC6 VWDE MEGF10 MASP2 OTOG | 2.61e-18 | 1026 | 68 | 25 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | CRISPLD2 HSPG2 FRAS1 THBS2 FBN2 VWF TNC NCAN LAMA2 KCP LAMA3 LAMA5 SSPOP VWDE OTOG | 2.88e-16 | 270 | 68 | 15 | MM17057 |
| Coexpression | NABA_MATRISOME | TPO PCSK5 CRISPLD2 VWC2 HSPG2 FRAS1 THBS2 FBN2 VWF MEGF8 TNC NCAN VWC2L LAMA2 KCP LAMA3 LAMA5 SSPOP MUC6 VWDE MEGF10 MASP2 OTOG | 3.44e-16 | 1008 | 68 | 23 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | CRISPLD2 FRAS1 THBS2 FBN2 VWF TNC LAMA2 KCP LAMA3 LAMA5 SSPOP VWDE OTOG | 2.39e-15 | 191 | 68 | 13 | MM17059 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 6.20e-08 | 40 | 68 | 5 | M5887 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 1.94e-07 | 20 | 68 | 4 | MM17053 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 9.13e-06 | 16 | 68 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 9.13e-06 | 16 | 68 | 3 | M2207 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.35e-05 | 200 | 68 | 6 | M5930 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.85e-05 | 23 | 68 | 3 | M48001 | |
| Coexpression | PEREZ_TP53_TARGETS | JAG2 CRISPLD2 LAMB4 DRAXIN ZNF398 KCP UNKL GRN GOLGA8A MEGF10 FBXO34 PEAR1 | 5.48e-05 | 1201 | 68 | 12 | M4391 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 6.45e-05 | 162 | 68 | 5 | M45037 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPITHELIAL_CELLS | 9.29e-05 | 175 | 68 | 5 | MM3643 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 1.42e-04 | 439 | 68 | 7 | M39054 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 1.54e-04 | 195 | 68 | 5 | M45684 | |
| Coexpression | GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN | 1.70e-04 | 199 | 68 | 5 | M9701 | |
| Coexpression | GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN | 1.70e-04 | 199 | 68 | 5 | M3554 | |
| Coexpression | GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN | 1.74e-04 | 200 | 68 | 5 | M6952 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 1.79e-04 | 780 | 68 | 9 | M2324 | |
| Coexpression | GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION | 1.91e-04 | 43 | 68 | 3 | MM926 | |
| Coexpression | GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION | 1.91e-04 | 43 | 68 | 3 | M2370 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_ASTROCYTES | 2.02e-04 | 326 | 68 | 6 | M39074 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 2.26e-04 | 805 | 68 | 9 | MM1067 | |
| Coexpression | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN | 2.34e-04 | 46 | 68 | 3 | M6679 | |
| Coexpression | KOMMAGANI_TP63_GAMMA_TARGETS | 2.36e-04 | 9 | 68 | 2 | M9630 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 3.59e-04 | 11 | 68 | 2 | M566 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.61e-08 | 189 | 68 | 7 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-08 | 197 | 68 | 7 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.30e-08 | 199 | 68 | 7 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.50e-07 | 157 | 68 | 6 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.49e-07 | 171 | 68 | 6 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.75e-07 | 174 | 68 | 6 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.47e-07 | 181 | 68 | 6 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.59e-07 | 182 | 68 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | wk_15-18-Epithelial-PNS-Early_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.70e-07 | 183 | 68 | 6 | 7e8366ec8117d36cec67f77dcb0e9a6032d87fcb | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.07e-07 | 186 | 68 | 6 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.20e-07 | 187 | 68 | 6 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.34e-07 | 188 | 68 | 6 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.34e-07 | 188 | 68 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.34e-07 | 188 | 68 | 6 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.47e-07 | 189 | 68 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-07 | 189 | 68 | 6 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-07 | 190 | 68 | 6 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-07 | 191 | 68 | 6 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.76e-07 | 191 | 68 | 6 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.76e-07 | 191 | 68 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-07 | 192 | 68 | 6 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-07 | 193 | 68 | 6 | 2d891c00b8f0aace17d4c300b63e2341dcffa199 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-07 | 194 | 68 | 6 | ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-07 | 195 | 68 | 6 | 841fde528ecb293e07b5e00e499d1e9f0b0dce14 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-07 | 195 | 68 | 6 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.37e-07 | 195 | 68 | 6 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-07 | 195 | 68 | 6 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.54e-07 | 196 | 68 | 6 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-07 | 196 | 68 | 6 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.70e-07 | 197 | 68 | 6 | a312d9cf4ced949307eb9620be4eed926300b892 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.70e-07 | 197 | 68 | 6 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.70e-07 | 197 | 68 | 6 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.70e-07 | 197 | 68 | 6 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.70e-07 | 197 | 68 | 6 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.87e-07 | 198 | 68 | 6 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.87e-07 | 198 | 68 | 6 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.87e-07 | 198 | 68 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.05e-07 | 199 | 68 | 6 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 6.05e-07 | 199 | 68 | 6 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 6.05e-07 | 199 | 68 | 6 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.05e-07 | 199 | 68 | 6 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 6.05e-07 | 199 | 68 | 6 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.05e-07 | 199 | 68 | 6 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.05e-07 | 199 | 68 | 6 | 258d59cf811bf1668ffbb5f18f961021f660de62 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.05e-07 | 199 | 68 | 6 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.23e-07 | 200 | 68 | 6 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.23e-07 | 200 | 68 | 6 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.23e-07 | 200 | 68 | 6 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.23e-07 | 200 | 68 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.02e-06 | 135 | 68 | 5 | 54b2aaf8d322e01a3ff6099c2422d68ecccf96b4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.97e-06 | 146 | 68 | 5 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.28e-06 | 149 | 68 | 5 | 1e77f03d2b32f366018fec3462d1b75f6e7febb9 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.62e-06 | 152 | 68 | 5 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-06 | 154 | 68 | 5 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.79e-06 | 161 | 68 | 5 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.40e-06 | 165 | 68 | 5 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Control / Condition, Lineage and Cell class | 5.73e-06 | 167 | 68 | 5 | ab6029ba037b6a499da8758864c44e174cde5587 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 5.73e-06 | 167 | 68 | 5 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-06 | 167 | 68 | 5 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.89e-06 | 168 | 68 | 5 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.24e-06 | 170 | 68 | 5 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.24e-06 | 170 | 68 | 5 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-06 | 171 | 68 | 5 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-06 | 171 | 68 | 5 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.80e-06 | 173 | 68 | 5 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.39e-06 | 176 | 68 | 5 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.81e-06 | 178 | 68 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-06 | 178 | 68 | 5 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.02e-06 | 179 | 68 | 5 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.02e-06 | 179 | 68 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.02e-06 | 179 | 68 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.02e-06 | 179 | 68 | 5 | 040a7e916baaf81f44339dc721ab2afcd2c22388 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 8.02e-06 | 179 | 68 | 5 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.02e-06 | 179 | 68 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-06 | 179 | 68 | 5 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.24e-06 | 180 | 68 | 5 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.24e-06 | 180 | 68 | 5 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.24e-06 | 180 | 68 | 5 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 181 | 68 | 5 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.46e-06 | 181 | 68 | 5 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 181 | 68 | 5 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.46e-06 | 181 | 68 | 5 | 9bfd93cf053beaee806cacdffd7abef02f94aec6 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 181 | 68 | 5 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.46e-06 | 181 | 68 | 5 | 7d7d1edeae4e0ebe40b324d1231cd26e27ba9d42 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.46e-06 | 181 | 68 | 5 | 6c55985e464cb0f5fb3362e9fd90351b671950f7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 181 | 68 | 5 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 181 | 68 | 5 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 181 | 68 | 5 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 181 | 68 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 181 | 68 | 5 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 181 | 68 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.69e-06 | 182 | 68 | 5 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.69e-06 | 182 | 68 | 5 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.69e-06 | 182 | 68 | 5 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-06 | 182 | 68 | 5 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-06 | 182 | 68 | 5 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 8.69e-06 | 182 | 68 | 5 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.93e-06 | 183 | 68 | 5 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.17e-06 | 184 | 68 | 5 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.17e-06 | 184 | 68 | 5 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| Computational | Adhesion molecules. | 1.05e-09 | 141 | 38 | 9 | MODULE_122 | |
| Computational | Spinal cord (neuro-development) genes. | 2.97e-05 | 360 | 38 | 8 | MODULE_12 | |
| Computational | DRG (dorsal root ganglia) genes. | 4.70e-05 | 384 | 38 | 8 | MODULE_2 | |
| Computational | Trachea genes. | 8.14e-05 | 415 | 38 | 8 | MODULE_6 | |
| Computational | ECM and collagens. | 1.24e-04 | 225 | 38 | 6 | MODULE_47 | |
| Computational | Placenta genes. | 1.04e-03 | 463 | 38 | 7 | MODULE_38 | |
| Computational | Ovary genes. | 1.69e-03 | 368 | 38 | 6 | MODULE_1 | |
| Computational | Intermediate filaments and MT. | 1.74e-03 | 68 | 38 | 3 | MODULE_438 | |
| Computational | Genes in the cancer module 311. | 1.80e-03 | 18 | 38 | 2 | MODULE_311 | |
| Computational | Intermediate filaments. | 2.31e-03 | 75 | 38 | 3 | MODULE_154 | |
| Computational | Intermediate filaments and keratins. | 2.78e-03 | 80 | 38 | 3 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 2.78e-03 | 80 | 38 | 3 | MODULE_297 | |
| Drug | kalinin | 1.34e-08 | 55 | 67 | 6 | CID000032518 | |
| Drug | AC1L1G72 | 2.22e-08 | 11 | 67 | 4 | CID000003553 | |
| Drug | LMWH | SCARF1 HSPG2 LAMB4 ERBB3 THBS2 ERBB4 VWF PROZ TNC LAMA2 LAMA3 LAMA5 MASP2 | 5.76e-08 | 663 | 67 | 13 | CID000000772 |
| Drug | Rgd Peptide | 5.02e-07 | 239 | 67 | 8 | CID000104802 | |
| Drug | AC1L9INI | 8.39e-07 | 59 | 67 | 5 | CID000445839 | |
| Drug | LG 5 | 9.13e-07 | 60 | 67 | 5 | CID011840957 | |
| Drug | AC1O0B8G | 1.00e-06 | 262 | 67 | 8 | CID000091605 | |
| Drug | AC1L1B58 | 1.54e-06 | 29 | 67 | 4 | CID000001288 | |
| Drug | 2-amino-5-methylpyridine | 3.18e-06 | 77 | 67 | 5 | CID000015348 | |
| Drug | BM165 | 3.95e-06 | 11 | 67 | 3 | CID003352881 | |
| Drug | Calcort | 4.69e-06 | 38 | 67 | 4 | CID000026709 | |
| Drug | NSC 714187 | 5.18e-06 | 85 | 67 | 5 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 5.49e-06 | 86 | 67 | 5 | CID000001322 | |
| Drug | sulfate | SCARF1 HSPG2 LAMB4 ERBB3 THBS2 ERBB4 VWF SCARF2 TNC NCAN DNER LAMA2 LAMA3 LAMA5 | 1.93e-05 | 1292 | 67 | 14 | CID000001117 |
| Drug | CC270 | 2.76e-05 | 59 | 67 | 4 | CID006918852 | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 3.80e-05 | 314 | 67 | 7 | CID000003542 | |
| Drug | Sikvav | 4.72e-05 | 24 | 67 | 3 | CID005487517 | |
| Drug | PD168393 | 5.10e-05 | 4 | 67 | 2 | CID000004708 | |
| Drug | gamma-secretase inhibitor I | 5.10e-05 | 4 | 67 | 2 | CID011754711 | |
| Drug | 1-piperidinocyclohexanecarbonitrile | 5.35e-05 | 25 | 67 | 3 | CID000062529 | |
| Drug | AC1NE3ZR | 6.03e-05 | 26 | 67 | 3 | CID004636208 | |
| Drug | 1-alpha-25-dihydroxycholecalciferol | SCARF1 JAG2 PCSK5 LAMB4 ERBB3 ERBB4 SCARF2 DNER LAMA2 LAMA3 LAMA5 | 6.42e-05 | 909 | 67 | 11 | CID000002524 |
| Drug | dysprosium | 6.75e-05 | 74 | 67 | 4 | CID000023912 | |
| Drug | benzylidenemalononitrile | 6.77e-05 | 27 | 67 | 3 | CID000017608 | |
| Drug | RG 14921 | 8.48e-05 | 5 | 67 | 2 | CID000197517 | |
| Drug | 6-quinolinecarbaldehyde | 8.48e-05 | 5 | 67 | 2 | CID000765653 | |
| Drug | YIGSR | 8.72e-05 | 79 | 67 | 4 | CID000123977 | |
| Drug | procymidone | 9.42e-05 | 155 | 67 | 5 | ctd:C035988 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.06e-04 | 83 | 67 | 4 | CID011968896 | |
| Drug | lead stearate | 1.11e-04 | 84 | 67 | 4 | CID000061258 | |
| Drug | pyrachlostrobin | CRISPLD2 HSPG2 THBS2 TNC LAMA5 GRN MEGF10 NOTCH2 NOTCH3 CRB2 | 1.23e-04 | 811 | 67 | 10 | ctd:C513428 |
| Drug | hyaluronan | 1.24e-04 | 263 | 67 | 6 | CID000024759 | |
| Drug | SnCe6 | 1.27e-04 | 6 | 67 | 2 | CID000164259 | |
| Drug | Cochliobolic acid | 1.27e-04 | 6 | 67 | 2 | CID006450172 | |
| Drug | vgBE | 1.27e-04 | 6 | 67 | 2 | CID000193461 | |
| Drug | diethyl ester | 1.27e-04 | 6 | 67 | 2 | CID000264327 | |
| Drug | H-9 dihydrochloride | 1.45e-04 | 90 | 67 | 4 | CID000003544 | |
| Drug | Sc 356 | 1.77e-04 | 7 | 67 | 2 | CID000022975 | |
| Drug | SSFSB | 1.77e-04 | 7 | 67 | 2 | CID003035734 | |
| Drug | RG 14467 | 1.77e-04 | 7 | 67 | 2 | CID000132069 | |
| Drug | MW167 | 1.77e-04 | 7 | 67 | 2 | CID010312597 | |
| Disease | intestinal cancer (implicated_via_orthology) | 6.91e-07 | 32 | 64 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of skin | 8.37e-06 | 59 | 64 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 8.37e-06 | 59 | 64 | 4 | C0037286 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 4.61e-05 | 5 | 64 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 9.66e-05 | 7 | 64 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 9.66e-05 | 7 | 64 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Hepatic fibrosis | 1.67e-04 | 49 | 64 | 3 | HP_0001395 | |
| Disease | serum selenium measurement | 2.11e-04 | 53 | 64 | 3 | EFO_0005266 | |
| Disease | Bladder Neoplasm | 2.47e-04 | 140 | 64 | 4 | C0005695 | |
| Disease | gallbladder neoplasm | 2.52e-04 | 11 | 64 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 2.52e-04 | 11 | 64 | 2 | C0153452 | |
| Disease | Malignant neoplasm of urinary bladder | 2.54e-04 | 141 | 64 | 4 | C0005684 | |
| Disease | vascular brain injury measurement, vascular brain injury | 3.56e-04 | 13 | 64 | 2 | EFO_0006791, EFO_0006800 | |
| Disease | median neuropathy (biomarker_via_orthology) | 4.14e-04 | 14 | 64 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 4.77e-04 | 15 | 64 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 4.77e-04 | 15 | 64 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 4.77e-04 | 15 | 64 | 2 | C0154091 | |
| Disease | Bipolar Disorder | 5.87e-04 | 477 | 64 | 6 | C0005586 | |
| Disease | Dementia | 6.17e-04 | 17 | 64 | 2 | C0497327 | |
| Disease | Glioblastoma | 6.84e-04 | 79 | 64 | 3 | C0017636 | |
| Disease | Carcinoma of bladder | 6.93e-04 | 18 | 64 | 2 | C0699885 | |
| Disease | carotid artery disease (is_marker_for) | 7.73e-04 | 19 | 64 | 2 | DOID:3407 (is_marker_for) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 7.73e-04 | 19 | 64 | 2 | DOID:2876 (is_marker_for) | |
| Disease | bipolar disorder (is_marker_for) | 7.73e-04 | 19 | 64 | 2 | DOID:3312 (is_marker_for) | |
| Disease | thyroxine measurement | 7.90e-04 | 83 | 64 | 3 | EFO_0005130 | |
| Disease | Giant Cell Glioblastoma | 8.18e-04 | 84 | 64 | 3 | C0334588 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.62e-04 | 195 | 64 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | retinal vasculature measurement | 8.92e-04 | 517 | 64 | 6 | EFO_0010554 | |
| Disease | stomach carcinoma (is_marker_for) | 1.24e-03 | 24 | 64 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Carcinoma, Pancreatic Ductal | 1.24e-03 | 24 | 64 | 2 | C0887833 | |
| Disease | brain cancer (implicated_via_orthology) | 1.46e-03 | 26 | 64 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 1.83e-03 | 111 | 64 | 3 | C1621958 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.94e-03 | 30 | 64 | 2 | DOID:9256 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CAHFRDGPHCVSSCP | 576 | P21860 | |
| DRECHPCHPNCTQGC | 611 | Q15303 | |
| FPEAVACGDGHHCCP | 86 | P28799 | |
| IPEAVCCSDHQHCCP | 391 | P28799 | |
| QPEPFACGIEHCSVH | 176 | Q9NWN3 | |
| VCELHLHPDCVPFAC | 151 | P52824 | |
| TRGHIHPACPCQQSC | 71 | A8MUL3 | |
| SCALHACPPHCNNAE | 106 | Q96MC9 | |
| LHCHPEACGPDATCV | 3886 | P98160 | |
| VPHCADKCVHGRCIA | 106 | Q96KG7 | |
| CHHSAVPVDGCNCPD | 691 | Q6W4X9 | |
| IDNCDPDPCHHGQCQ | 571 | Q04721 | |
| CHPTCRQCHGPLESD | 761 | Q86XX4 | |
| AVHGSCRACPCPHTN | 1726 | Q16787 | |
| CPHCQKENPQHVDIC | 276 | Q8TAT5 | |
| CATQPCHHGALCVPQ | 71 | Q5IJ48 | |
| CEAHVDPCHSAPCAR | 1091 | Q5IJ48 | |
| APVPDCLGVHCDFHQ | 416 | Q9BTV5 | |
| SCHEVPSGFECHCPS | 361 | Q9Y219 | |
| HCHCPQGFSGPLCEV | 521 | Q9Y219 | |
| ACDIPHCTDNCGFPH | 281 | O75882 | |
| LPCPDNCELCHSVHV | 986 | Q92824 | |
| PQDTHGPGCQEHCLC | 396 | Q5VY43 | |
| DVNECADGAHPPCHA | 796 | P07202 | |
| THCPRIHCPAHCKDE | 406 | Q9H0B8 | |
| VDDCSPDPCHHGRCV | 546 | Q9UM47 | |
| CPPEDECANGHHDCN | 2176 | Q7Z7M0 | |
| KCGNHTCSQVCHPQP | 566 | Q12986 | |
| VSCTPPSCCQLHHAE | 136 | Q07627 | |
| VSCTPPTCCQLHHAE | 126 | Q8IUG1 | |
| GCVHFPHTAPCEVRV | 496 | Q71SY5 | |
| CQPCHCDPIGSLNEV | 411 | P24043 | |
| HACPAGCACTDPHTV | 26 | Q5VT99 | |
| CVPCQCHGHSDRCLP | 1861 | O15230 | |
| TSPAEGEPCDHHQDC | 266 | Q8NBI3 | |
| GEPCDHHQDCLPGTC | 271 | Q8NBI3 | |
| VVACSVEPCPHTVDC | 161 | Q9NTQ9 | |
| ECQVAPGEAPTCDHH | 141 | O00187 | |
| AHCLTVTPQHGCVAP | 2171 | Q8TEP8 | |
| HGIPCCEVHIGDVCL | 321 | O60381 | |
| PCHCHPQGSKDTVCD | 816 | A4D0S4 | |
| CQETCGEPTSCQPVH | 56 | Q6PEX3 | |
| AHTCRCGVPACSHVP | 231 | Q8N1N5 | |
| TRAHVECPPAHTCPC | 366 | Q8N1N5 | |
| CKCPPGFTQHHTACI | 2556 | P35556 | |
| CQLVADPCASNPCHH | 91 | Q8NFT8 | |
| TVCDCHGHVETCPGP | 636 | P22223 | |
| GCCQHQCQAPDTIVP | 2456 | Q6ZRI0 | |
| HQEHPGLGSNCCVPC | 606 | A7E2F4 | |
| VCVPTQDCPCAHEGH | 3136 | A2VEC9 | |
| HPRDPCQECRCQEGH | 561 | Q6ZWJ8 | |
| GQQTCLPVHPRCHAC | 286 | P78549 | |
| EVHSDPCENNPCLHG | 1006 | O14594 | |
| VVCVHEPRCQPPDCH | 321 | Q9UK23 | |
| DHKQCVPHDQCACGV | 161 | P22891 | |
| CELQPHCELQPHCEQ | 1291 | Q9P2P6 | |
| HPHGQCEPATGACQC | 106 | Q14162 | |
| TCDEEHCNPPCQHGG | 1356 | Q8N2E2 | |
| HPRCIHVDTSQCCPQ | 196 | Q2TAL6 | |
| EPLACPVQCVEGCHA | 1161 | P04275 | |
| PSDPEHCQICHCDVV | 1216 | P04275 | |
| VCHDHDGECVCPPGF | 236 | P35590 | |
| CPPCRDGHACNHVTG | 331 | Q96GP6 | |
| QCSHATEHPLPCAQC | 361 | Q8TD17 | |
| FPCPVCRHQCQEGHF | 51 | A6NK02 | |
| VCPERCDCQHPQHLL | 26 | Q7L0X0 | |
| ICPVPCSEEHGTCVD | 251 | P24821 | |
| HTPVEDTCNDLCHPG | 971 | O60281 | |
| VSSPHCEEPCAHSCA | 111 | P0DPA3 | |
| PIHSCEVQPTHCGQD | 131 | Q6ZUG5 | |
| HHILCEPCAATAPEC | 656 | Q9H9P5 | |
| QAVHTADRPHCCPDC | 476 | A6NFI3 | |
| HCVVADCAVPECVNP | 146 | B2RUY7 | |
| CAVPDHSCEGPKHGC | 431 | Q9H5U6 | |
| HVDHIVLDLECCPCP | 431 | Q53H54 | |
| VGDHCDNCPLVHNPD | 831 | P35442 | |
| GPVHLHCSVSVCQPA | 436 | Q12836 | |
| PRCCCLAVVAQCPHH | 51 | Q9H379 |